Geraldine Cambridge

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Jo Cambridge)
Jump to: navigation, search

Doctor Geraldine Cambridge, also known as Jo Cambridge, is Principal Research Fellow, Inflammation, Division of Medicine, Faculty of Medical Sciences, University College London in the United Kingdom. She has previously worked with Jonathan Edwards in rheumatoid arthritis Rituximab research.

She spoke at the Invest in ME International ME Conferences in 2015 and 2016 about immunoregulation in patients with ME and the IiME Rituximab study.[1][2]

Dr. Cambridge is the Principal Investigator of the Invest in ME UK RITUXIMAB Clinical Trial and B-Cell Research, along with a team from Rayne Institute, University College London,London.[3]

Awards[edit | edit source]

Talks & interviews[edit | edit source]

Notable Studies[edit | edit source]

See Also[edit | edit source]

References[edit | edit source]

  1. http://www.investinme.eu/IIMEC11.shtml#home
  2. http://www.investinme.eu/IIMEC10.shtml#dvd
  3. http://www.ukrituximabtrial.org/Rituximab%20news-Aug14%2002.htm
  4. http://solvecfs.org/2016-ramsay-award-program-results/
  5. http://www.investinme.eu/iimec12.shtml
  6. http://www.investinme.eu/IIMEC11.shtml#agenda
  7. http://www.investinme.eu/IIMEC10.shtml
  8. Mensah, Fane; Bansal, Amolak; Ford, Brian; Cambridge, Geraldine (2017), "Chronic fatigue syndrome and the immune system: Where are we now?", Neurophysiologie Clinique, 47 (2): 131-138, doi:10.1016/j.neucli.2017.02.002 
  9. Mensah, Fane; Bansal, Amolak; Berkovitz, Saul; Sharma, Arti; Reddy, Venkat; Leandro, Maria; Cambridge, Geraldine (2016), "Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study", Clinical and Experimental Immunology, 184 (2): 237-247, doi:10.1111/cei.12749 


The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history